Clinical characteristics of patients with Atrial Fibrillation
DOI:
https://doi.org/10.18537/RFCM.39.01.02Keywords:
atrial fibrillation, thromboembolism, anticoagulantsAbstract
Objective: to characterize Atrial Fibrillation (AF) to determine the frequency of the main comorbidities of atrial fibrillation, the thromboembolic risk and the main therapeutic strategy in patients of the Hospital “José Carrasco Arteaga” in Cuenca city.
Methodology: it is a descriptive study with a universe of 297 patients with a diagnosis of Atrial Fibrillation at the José Carrasco Arteaga Hospital, during 2017. The information was collected in a form prepared by the authors and analyzed with the PSPP Free Software Foundation, and Epidat programs 4.1 using frequency, percentage and mean distributions.
Results: a total of 52.5% of the studied population were men; the most frequent comorbidity was arterial hypertension in 50.5% of the cases; nonvalvular Atrial Fibrillation represented 82.5% of the cases, the thromboembolic risk was high in 77.1% of the patients with non-valvular atrial fibrillation; anticoagulation was the therapeutic strategy in 67% of patients.
Conclusion: the clinical characteristics of patients with AF in our city are consistent with those of similar populations. Most are men, older adults, and hypertensive. High embolic risk was predominant, consequently warfarin was the most used drug
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Fernando Xavier Balarezo Arias

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright © Autors.

You are free to:
![]() |
Share — copy and redistribute the material in any medium or format |
![]() |
Adapt — remix, transform, and build upon the material for any purpose, even commercially. |
Under the following conditions:
![]() |
Attribution — You must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licenser endorses you or your use. |
| NonCommercial — You may not use the material for commercial purposes. | |
| ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. |
| No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the licence permits. |






